Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT07481526

A Prospecitve Multicenter, Observational Registry Study

Conditions: Chronic Kidney Disease

Sex: All

Healthy volunteers: No

Enrollment: 3000

Sponsor: AstraZeneca

Location: Zhongshan Hospital Affilicated with Fudan University Shanghai

Summary

This is a prospective, multicenter, observational registry study designed to collect data to deepen the understanding of CKD therapeutics, changes in clinical practice, cardiorenal risk outcomes and differences in treatment approaches in Chinese CKD patients.

Eligibility Criteria

Inclusion Criteria: * Male or female patients aged ≥18 years. * Willing and able to provide written informed consent to participate in the study. * Confirmed CKD diagnosis at enrolment, defined by at least one of the following: * eGFR \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07481526). StuddyBuddy aggregates publicly available trial information.